BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 35181473)

  • 1. Chemokines and cytokines: Axis and allies in prostate cancer pathogenesis.
    Mughees M; Kaushal JB; Sharma G; Wajid S; Batra SK; Siddiqui JA
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):497-512. PubMed ID: 35181473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of proinflammatory cytokines and CXC chemokines (CXCL1-CXCL16) in the progression of prostate cancer: insights on their therapeutic management.
    Ullah A; Jiao W; Shen B
    Cell Mol Biol Lett; 2024 May; 29(1):73. PubMed ID: 38745115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer.
    Song N; Cui K; Zeng L; Li M; Fan Y; Shi P; Wang Z; Su W; Wang H
    Eur J Pharmacol; 2024 Mar; 967():176357. PubMed ID: 38309677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy.
    Bhat AA; Nisar S; Singh M; Ashraf B; Masoodi T; Prasad CP; Sharma A; Maacha S; Karedath T; Hashem S; Yasin SB; Bagga P; Reddy R; Frennaux MP; Uddin S; Dhawan P; Haris M; Macha MA
    Cancer Commun (Lond); 2022 Aug; 42(8):689-715. PubMed ID: 35791509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis.
    Adekoya TO; Richardson RM
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32585812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging roles of chemokines in prostate cancer.
    Vindrieux D; Escobar P; Lazennec G
    Endocr Relat Cancer; 2009 Sep; 16(3):663-73. PubMed ID: 19556286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy.
    Bhat AA; Nisar S; Maacha S; Carneiro-Lobo TC; Akhtar S; Siveen KS; Wani NA; Rizwan A; Bagga P; Singh M; Reddy R; Uddin S; Grivel JC; Chand G; Frenneaux MP; Siddiqi MA; Bedognetti D; El-Rifai W; Macha MA; Haris M
    Mol Cancer; 2021 Jan; 20(1):2. PubMed ID: 33390169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies.
    Baci D; Bruno A; Cascini C; Gallazzi M; Mortara L; Sessa F; Pelosi G; Albini A; Noonan DM
    J Exp Clin Cancer Res; 2019 Nov; 38(1):464. PubMed ID: 31718684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MT1G, an emerging ferroptosis-related gene: A novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer.
    Cheng B; Lai Y; Huang H; Peng S; Tang C; Chen J; Luo T; Wu J; He H; Wang Q; Huang H
    Environ Toxicol; 2024 Feb; 39(2):927-941. PubMed ID: 37972062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy.
    Bule P; Aguiar SI; Aires-Da-Silva F; Dias JNR
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-inflammatory cytokines and chemokines initiate multiple prostate cancer biologic pathways of cellular proliferation, heterogeneity and metastasis in a racially diverse population and underlie the genetic/biologic mechanism of racial disparity: Update.
    Powell IJ; Chinni SR; Reddy SS; Zaslavsky A; Gavande N
    Urol Oncol; 2021 Jan; 39(1):34-40. PubMed ID: 32900629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins.
    Nasser MW; Elbaz M; Ahirwar DK; Ganju RK
    Cancer Lett; 2015 Aug; 365(1):11-22. PubMed ID: 25963887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Challenges and Emerging Opportunities of Targeting Cytokines and Chemokine-Driven Inflammatory Signals in Metastatic Castrate-Resistant Prostate Cancer.
    Waugh DJJ; McGovern JA; McCusker S
    Crit Rev Oncog; 2022; 27(1):25-43. PubMed ID: 35993977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 3: PD-L1, Intracellular Signaling Pathways and Tumor Microenvironment.
    Palicelli A; Croci S; Bisagni A; Zanetti E; De Biase D; Melli B; Sanguedolce F; Ragazzi M; Zanelli M; Chaux A; CaƱete-Portillo S; Bonasoni MP; Soriano A; Ascani S; Zizzo M; Castro Ruiz C; De Leo A; Giordano G; Landriscina M; Carrieri G; Cormio L; Berney DM; Gandhi J; Copelli V; Bernardelli G; Santandrea G; Bonacini M
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of chemokine signaling with non-coding RNAs in tumor microenvironment and heterogeneity in different cancers.
    Arora S; Khan S; Zaki A; Tabassum G; Mohsin M; Bhutto HN; Ahmad T; Fatma T; Syed MA
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):720-736. PubMed ID: 35257861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifaceted role of chemokines in solid tumors: From biology to therapy.
    Raza S; Rajak S; Tewari A; Gupta P; Chattopadhyay N; Sinha RA; Chakravarti B
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):1105-1121. PubMed ID: 34979274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokines and receptors in the development and progression of malignant tumors.
    Zhao HQ; Jiang J
    Cytokine; 2023 Oct; 170():156335. PubMed ID: 37591136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling.
    Xie T; Fu DJ; Li ZM; Lv DJ; Song XL; Yu YZ; Wang C; Li KJ; Zhai B; Wu J; Feng NH; Zhao SC
    Mol Cancer; 2022 Sep; 21(1):173. PubMed ID: 36045408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in landscape and related therapeutic targets of the prostate tumor microenvironment.
    Li D; Xu W; Chang Y; Xiao Y; He Y; Ren S
    Acta Biochim Biophys Sin (Shanghai); 2023 Jun; 55(6):956-973. PubMed ID: 37294106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Icariin inhibits prostate cancer bone metastasis and destruction via suppressing TAM/CCL5-mediated osteoclastogenesis.
    Chen C; Wang S; Wang N; Zheng Y; Zhou J; Hong M; Chen Z; Wang S; Wang Z; Xiang S
    Phytomedicine; 2023 Nov; 120():155076. PubMed ID: 37716031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.